Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Observational Study on Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections - DALBADIA Study

NCT04959799 is registered in ClinicalTrials.gov with Aziende Chimiche Riunite Angelini Francesco S.p.A as lead sponsor.

NCT NCT04959799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04959799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Observational Study on Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections - DALBADIA Study
Lead sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A
Phase
Observational
Overall status
Completed
Start date
January 2, 2022
Completion date
May 31, 2022
Enrollment
98 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, infection